eXoZymes
EXOZ | NASDAQ
$3.99
+$0.16 (+4.18%)
At close: Nov 16, 2026, 4:00 PM ET
$3.92
-$0.07 (-1.75%)
After-hours:
Nov 16, 2026, 7:30 PM ET
+4.18%
(1D)Rating
13.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1015/1021 (Top 99%)
Key Statistics
Market Data
Market Cap $37.03M
1D Range
3.67 3.99
52W Range
3.67 16.18
Valuation (TTM)
PE -3.41
PB 16.90
EV/EBITDA -3.06
Valuation (NTM)
Forward PE N/A
Forward PEG -1.30
Price Target $0.00
Cash Flow
FCF Yield -21.1%
SBC Adj. FCF Yield -29.6%
SBC Impact -40.7%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y -26.8% |
N/A
FCF 3Y | 5Y -26.5% |
N/A
Returns
ROA -173.0%
ROE -376.7%
ROIC -242.7%
Financial Health
Net Cash
$2.26M
Current Ratio 2.30
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The compan...
Sector Healthcare
Industry Biotechnology
Employees 32
IPO Date Nov 13, 2024
Website exozymes.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove EXOZ